HLA-DRB1 and disease outcome in multiple sclerosis

Journal of Neurology

Volumn 248, Issue 4, 2001, Pages 304-310

  Weatherby, S J M ^a   Thomson, W ^b   Pepper, L ^b   Donn, R ^b   Worthington, J ^b   Mann, C L A ^a   Davies, M B ^b   Fryer, A A ^c   Boggild, M D ^c   Young, C A ^c   Jones, P W ^d   Strange, R C ^a   Ollier, W E R ^b   Hawkins, C P ^a  

^a Postgraduate Medical School   (United Kingdom)

^b University Medical School   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Disability; HLA; Multiple sclerosis; Susceptibility

Indexed keywords

HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CHRONICITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 0035053942     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170205     Document Type: Article

References (36)

1. HLA antigens in systemic lupus erythematosus: Relationship to disease severity, age at onset, sex
2. Interaction between sex and HLA in a population study
3. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen
4. Genetic epidemiology of multiple sclerosis
5. Genetic susceptibility to multiple sclerosis
6. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
7. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression
8. Genetics of multiple sclerosis
9. A full genome search in multiple sclerosis
10. HLA and heterogeneity of multiple sclerosis
11. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group
12. Association of tumour necrosis factor microsatellite polymorphisms with HLA-DRB1*04 bearing haplotypes in rheumatoid arthritis patients
13. HLA and rheumatoid arthritis: Susceptibility or severity?
14. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis
15. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
16. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset and disease activity
17. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes
18. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor
19. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis
20. HLA class II genes in chronic progressive and in relapsing/remitting multiple sclerosis
21. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two im-munogenetically distinct disease entities
22. Results of the 3-year, double blind, placebo-controlled study of interferon beta-1a (Rebif) in secondary-progressive MS
23. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease
24. What's wrong with Bonferroni adjustments
25. Association of tumour necrosis factor (TNF-α) and II major histocompatibility complex alleles with the secretion of TNF-α and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus
26. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
27. HLA-antigens and the prognosis of multiple sclerosis
28. Prediction of outcome in multiple sclerosis based on multivariate models
29. HLA and prognosis in multiple sclerosis
30. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
31. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity
32. The natural history of multiple sclerosis
33. The natural history of multiple sclerosis
34. The natural history of multiple sclerosis: A geographically based study. III. Multivariate analysis of predictive factors and models of outcome
35. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study
36. Multiple sclerosis susceptibility. Interaction between sex and HLA